Rhabdomyolysis with concurrent atorvastatin and diltiazem
To report a case of rhabdomyolysis and acute hepatitis associated with the coadministration of atorvastatin and diltiazem. A 60-year-old African American man with a significant past medical history presented to the emergency department with acute renal failure secondary to rhabdomyolysis. In additio...
Gespeichert in:
| Veröffentlicht in: | The Annals of pharmacotherapy Jg. 36; H. 10; S. 1546 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
01.10.2002
|
| Schlagworte: | |
| ISSN: | 1060-0280 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | To report a case of rhabdomyolysis and acute hepatitis associated with the coadministration of atorvastatin and diltiazem.
A 60-year-old African American man with a significant past medical history presented to the emergency department with acute renal failure secondary to rhabdomyolysis. In addition, liver enzymes were elevated to greater than 3 times normal. The only change in medication was the initiation of diltiazem 3 weeks earlier for atrial fibrillation to a complicated medication regimen that included atorvastatin.
Rhabdomyolysis has been reported in patients receiving hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors when coadministered with agents that may inhibit their metabolism. Atorvastatin is the most potent of this class of agents currently available and is commonly used in the treatment of hyperlipidemia. Rhabdomyolysis resulting from the drug interaction between diltiazem and other HMG-CoA reductase inhibitors has been described in the literature. However, no report has specifically associated this adverse event with atorvastatin and diltiazem. We describe a patient with a complex medication regimen who was admitted for rhabdomyolysis and accompanying acute renal failure, along with acute hepatitis, thought to be secondary to a drug interaction between atorvastatin and diltiazem.
While optimizing the patient's lipid profile should be the primary factor in choosing one statin over another, the potential for drug interactions requires close attention. All patients beginning HMG-CoA reductase inhibitor therapy should be counseled regarding the signs and symptoms of muscle injury; particular attention should be paid to those patients who are taking medications that may interact. |
|---|---|
| AbstractList | To report a case of rhabdomyolysis and acute hepatitis associated with the coadministration of atorvastatin and diltiazem.OBJECTIVETo report a case of rhabdomyolysis and acute hepatitis associated with the coadministration of atorvastatin and diltiazem.A 60-year-old African American man with a significant past medical history presented to the emergency department with acute renal failure secondary to rhabdomyolysis. In addition, liver enzymes were elevated to greater than 3 times normal. The only change in medication was the initiation of diltiazem 3 weeks earlier for atrial fibrillation to a complicated medication regimen that included atorvastatin.CASE SUMMARYA 60-year-old African American man with a significant past medical history presented to the emergency department with acute renal failure secondary to rhabdomyolysis. In addition, liver enzymes were elevated to greater than 3 times normal. The only change in medication was the initiation of diltiazem 3 weeks earlier for atrial fibrillation to a complicated medication regimen that included atorvastatin.Rhabdomyolysis has been reported in patients receiving hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors when coadministered with agents that may inhibit their metabolism. Atorvastatin is the most potent of this class of agents currently available and is commonly used in the treatment of hyperlipidemia. Rhabdomyolysis resulting from the drug interaction between diltiazem and other HMG-CoA reductase inhibitors has been described in the literature. However, no report has specifically associated this adverse event with atorvastatin and diltiazem. We describe a patient with a complex medication regimen who was admitted for rhabdomyolysis and accompanying acute renal failure, along with acute hepatitis, thought to be secondary to a drug interaction between atorvastatin and diltiazem.DISCUSSIONRhabdomyolysis has been reported in patients receiving hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors when coadministered with agents that may inhibit their metabolism. Atorvastatin is the most potent of this class of agents currently available and is commonly used in the treatment of hyperlipidemia. Rhabdomyolysis resulting from the drug interaction between diltiazem and other HMG-CoA reductase inhibitors has been described in the literature. However, no report has specifically associated this adverse event with atorvastatin and diltiazem. We describe a patient with a complex medication regimen who was admitted for rhabdomyolysis and accompanying acute renal failure, along with acute hepatitis, thought to be secondary to a drug interaction between atorvastatin and diltiazem.While optimizing the patient's lipid profile should be the primary factor in choosing one statin over another, the potential for drug interactions requires close attention. All patients beginning HMG-CoA reductase inhibitor therapy should be counseled regarding the signs and symptoms of muscle injury; particular attention should be paid to those patients who are taking medications that may interact.CONCLUSIONSWhile optimizing the patient's lipid profile should be the primary factor in choosing one statin over another, the potential for drug interactions requires close attention. All patients beginning HMG-CoA reductase inhibitor therapy should be counseled regarding the signs and symptoms of muscle injury; particular attention should be paid to those patients who are taking medications that may interact. To report a case of rhabdomyolysis and acute hepatitis associated with the coadministration of atorvastatin and diltiazem. A 60-year-old African American man with a significant past medical history presented to the emergency department with acute renal failure secondary to rhabdomyolysis. In addition, liver enzymes were elevated to greater than 3 times normal. The only change in medication was the initiation of diltiazem 3 weeks earlier for atrial fibrillation to a complicated medication regimen that included atorvastatin. Rhabdomyolysis has been reported in patients receiving hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors when coadministered with agents that may inhibit their metabolism. Atorvastatin is the most potent of this class of agents currently available and is commonly used in the treatment of hyperlipidemia. Rhabdomyolysis resulting from the drug interaction between diltiazem and other HMG-CoA reductase inhibitors has been described in the literature. However, no report has specifically associated this adverse event with atorvastatin and diltiazem. We describe a patient with a complex medication regimen who was admitted for rhabdomyolysis and accompanying acute renal failure, along with acute hepatitis, thought to be secondary to a drug interaction between atorvastatin and diltiazem. While optimizing the patient's lipid profile should be the primary factor in choosing one statin over another, the potential for drug interactions requires close attention. All patients beginning HMG-CoA reductase inhibitor therapy should be counseled regarding the signs and symptoms of muscle injury; particular attention should be paid to those patients who are taking medications that may interact. |
| Author | Nappi, Jean M Taylor, Marian H Lewin, 3rd, John J |
| Author_xml | – sequence: 1 givenname: John J surname: Lewin, 3rd fullname: Lewin, 3rd, John J email: jlewin@umm.edu organization: Critical Care Pharmacy Practice, College of Pharmacy, Medical University of South Carolina, Charleston, SC, USA. jlewin@umm.edu – sequence: 2 givenname: Jean M surname: Nappi fullname: Nappi, Jean M – sequence: 3 givenname: Marian H surname: Taylor fullname: Taylor, Marian H |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/12243603$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1j8tKxDAUQLMYcR668AekK3cdc5NmkiyHwRcMCKLrcpukNNImY5Mq49crOK7O5nDgLMksxOAIuQK6Bl6JWzx0a9hWCmZkAXRDS8oUnZNlSu-UUg1Mn5M5MFbxDeULol86bGwcjrE_Jp-KL5-7wsRgpnF0IReY4_iJKWP2ocBgC-v77PHbDRfkrMU-ucsTV-Tt_u5191junx-edtt9abiscmlaUMqh1kDBGc5pu-G2cSishVZKVEpii00FjjPDOJdaCJRaORDKSkPZitz8dQ9j_JhcyvXgk3F9j8HFKdWSAYAQ6le8PolTMzhbH0Y_4His_2fZD2OVVdU |
| CitedBy_id | crossref_primary_10_1517_14740338_2011_540568 crossref_primary_10_1177_0091270009358082 crossref_primary_10_1111_j_1524_6175_2006_04482_x crossref_primary_10_1002_path_2018 crossref_primary_10_1097_MD_0000000000002487 crossref_primary_10_2217_clp_11_57 crossref_primary_10_1016_j_jcin_2012_10_005 crossref_primary_10_2165_00002018_200831070_00004 crossref_primary_10_2165_00128415_200209320_00021 crossref_primary_10_2478_acph_2013_0022 crossref_primary_10_1136_dtb_2020_231839rep crossref_primary_10_1161_01_CIR_0000131519_15067_1f crossref_primary_10_1517_14656566_7_13_1701 crossref_primary_10_1016_j_ajem_2004_09_025 crossref_primary_10_1007_s00044_009_9225_5 crossref_primary_10_1111_j_1365_2710_2010_01184_x crossref_primary_10_1016_j_biopha_2019_109416 crossref_primary_10_1002_prp2_439 crossref_primary_10_1016_j_lpm_2008_05_022 crossref_primary_10_1517_14740338_2012_712959 crossref_primary_10_1111_j_1399_0012_2004_00293_x crossref_primary_10_1124_dmd_114_057968 crossref_primary_10_1016_j_ncl_2004_12_014 crossref_primary_10_1161_CIR_0000000000000456 crossref_primary_10_1517_14740338_2_6_549 crossref_primary_10_2165_11319380_000000000_00000 crossref_primary_10_1136_bcr_2019_231839 crossref_primary_10_1177_0897190016674109 crossref_primary_10_1186_2193_1801_3_168 crossref_primary_10_1016_j_amjcard_2004_07_080 crossref_primary_10_1586_17512433_1_1_105 crossref_primary_10_1002_pds_789 crossref_primary_10_1016_j_farma_2011_02_010 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1345/aph.1A481 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| ExternalDocumentID | 12243603 |
| Genre | Journal Article Case Reports |
| GroupedDBID | --- -TM .GJ 01A 0R~ 0VX 1CY 23M 39C 4.4 53G 54M 5GY 5RE 6J9 6PF AABMB AACKU AACMV AACTG AADTT AADUE AAEWN AAGGD AAGMC AAJIQ AAJOX AAJPV AAKGS AAMGE AANSI AAPEO AAQQT AAQXH AAQXI AARDL AARIX AATAA AATBZ AAUAS AAWTL AAXOT AAYOK AAYTG AAZBJ ABAWP ABCCA ABCJG ABDWY ABEIX ABFWQ ABHKI ABJIS ABJNI ABKRH ABLUO ABOCM ABPGX ABPNF ABQKF ABQXT ABRHV ABUJY ABVFX ABVVC ABYTW ACARO ACDSZ ACDXX ACFEJ ACFMA ACFYK ACGBL ACGFO ACGFS ACGZU ACJER ACJTF ACLFY ACLHI ACLZU ACOFE ACOXC ACROE ACSBE ACSIQ ACTQU ACUAV ACUIR ACXKE ACXMB ADBBV ADEIA ADMPF ADNBR ADNON ADRRZ ADTBJ ADUKL ADVBO ADZZY AECGH AECVZ AEDTQ AEKYL AENEX AEPTA AEQLS AERKM AESZF AEUHG AEUIJ AEWDL AEWHI AEXFG AEXNY AFEET AFFNX AFKBI AFKRG AFMOU AFQAA AFUIA AGHKR AGKLV AGNHF AGPXR AGWFA AHDMH AHJOV AIGRN AIIQI AIOMO AIZAD AJABX AJEFB AJMMQ AJSCY AJUZI AJXAJ ALKWR ALMA_UNASSIGNED_HOLDINGS ALTZF AMCVQ ANDLU ARTOV AUTPY AUVAJ AYAKG B8M BBRGL BDDNI BKIIM BKSCU BPACV BSEHC BWJAD CBRKF CDWPY CFDXU CGR CORYS CQQTX CS3 CUTAK CUY CVF DB0 DC- DC. DC0 DD- DD0 DE- DE. DF0 DN0 DO- DOPDO DV7 EBS ECM EIF EJD EMOBN F5P FHBDP GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HZ~ J5H J8X K.F L7B LSO M4V NPM O9- P.9 P.B P2P Q1R ROL S01 SAUOL SCNPE SFC SHG SJN SPQ SPV THW UDS WH7 YCJ ZGI ZONMY ZPPRI ZRKOI ZSSAH ZXP 7X8 AAPII ABIDT ABJZC ADDLC ADEBD AJGYC AJHME AJVBE |
| ID | FETCH-LOGICAL-c374t-cf188ea99101ec330f63dbea5dd1f77a887afab41e32c2337955a798e158d7c02 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 32 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000178341100007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1060-0280 |
| IngestDate | Sun Nov 09 13:18:57 EST 2025 Wed Feb 19 01:30:26 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c374t-cf188ea99101ec330f63dbea5dd1f77a887afab41e32c2337955a798e158d7c02 |
| Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
| PMID | 12243603 |
| PQID | 72111558 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_72111558 pubmed_primary_12243603 |
| PublicationCentury | 2000 |
| PublicationDate | 2002-10-01 |
| PublicationDateYYYYMMDD | 2002-10-01 |
| PublicationDate_xml | – month: 10 year: 2002 text: 2002-10-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The Annals of pharmacotherapy |
| PublicationTitleAlternate | Ann Pharmacother |
| PublicationYear | 2002 |
| SSID | ssj0009129 |
| Score | 1.8933077 |
| Snippet | To report a case of rhabdomyolysis and acute hepatitis associated with the coadministration of atorvastatin and diltiazem.
A 60-year-old African American man... To report a case of rhabdomyolysis and acute hepatitis associated with the coadministration of atorvastatin and diltiazem.OBJECTIVETo report a case of... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1546 |
| SubjectTerms | Acute Disease Acute Kidney Injury - chemically induced Atorvastatin Calcium Cardiovascular Agents - adverse effects Cardiovascular Agents - therapeutic use Chemical and Drug Induced Liver Injury - etiology Diltiazem - adverse effects Diltiazem - therapeutic use Drug Interactions Heptanoic Acids - adverse effects Heptanoic Acids - therapeutic use Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Male Middle Aged Pyrroles - adverse effects Pyrroles - therapeutic use Rhabdomyolysis - chemically induced |
| Title | Rhabdomyolysis with concurrent atorvastatin and diltiazem |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/12243603 https://www.proquest.com/docview/72111558 |
| Volume | 36 |
| WOSCitedRecordID | wos000178341100007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEB6q9eDF96M-c5CeGrvZZDdZEKSIxYOWRSr0tmSzWVqwu9XWQv31JvugJ_HgJbdAGCYz82Uy3wdwQ6SS3NUMc6EDbPJtau6cI7HJLNqkO8Y0KwaFn_lgIEajIGzAXT0LY79V1jGxCNRJruwbedciFZP7xP3sA1vNKNtbrQQ0NqBJTSFjfZqP1lzhASk0ygzmcbBtIFa8QpR5XTkb35IeE-T3urLIL_3d_51sD3aquhL1SkfYh4bODqAdlsTUqw4arues5h3URuGasnp1CMHrWMZJPl3lBUMJsq-zyCBlVbI3IYvMl9IOH00yJLMEJZN3Exq-9fQI3vqPw4cnXIkqYEU5W2CVEiG0NGWhQ7Si1El9msRaeklCUs6lCToylTEjmrrKpZQHnid5IDTxRMKV4x7DZpZn-hSQiH0hFbGYxmOUBsLhroy1S3yhuKnEWnBdGywyTms7ETLT-dc8qk3WgpPS5tGs5NaIbKOP-g49-3PvOWyXyiz2Y90FNFNzXfUlbKnlYjL_vCp8wayD8OUHwhe_Kw |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rhabdomyolysis+with+concurrent+atorvastatin+and+diltiazem&rft.jtitle=The+Annals+of+pharmacotherapy&rft.au=Lewin%2C+3rd%2C+John+J&rft.au=Nappi%2C+Jean+M&rft.au=Taylor%2C+Marian+H&rft.date=2002-10-01&rft.issn=1060-0280&rft.volume=36&rft.issue=10&rft.spage=1546&rft_id=info:doi/10.1345%2Faph.1A481&rft_id=info%3Apmid%2F12243603&rft_id=info%3Apmid%2F12243603&rft.externalDocID=12243603 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1060-0280&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1060-0280&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1060-0280&client=summon |